1. Home >
  2. M&A >
  3. Special Situations/Distressed >
  4. United States >
  5. New Jersey >
  6. LEO Pharma Acquires Timber Pharmaceuticals

M&A Deal Summary

LEO Pharma Acquires Timber Pharmaceuticals

On January 23, 2024, LEO Pharma acquired life science company Timber Pharmaceuticals

Acquisition Highlights
  • This is LEO Pharma’s 2nd transaction in the Life Science sector.
  • This is LEO Pharma’s 2nd transaction in the United States.
  • This is LEO Pharma’s 1st transaction in New Jersey.

M&A Deal Summary
Date 2024-01-23
Target Timber Pharmaceuticals
Sector Life Science
Buyer(s) LEO Pharma
Deal Type Special Situations/Distressed

Target

Timber Pharmaceuticals

Basking Ridge, New Jersey, United States
Timber Pharmaceuticals is a specialty pharmaceutical company focused on developing prescription products utilizing its proprietary hyantX topical delivery system for dermatology indications. Timber Pharmaceuticals is based in Basking Ridge, New Jersey.

Search 214,239 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

LEO Pharma

Ballerup, Denmark
Category Company
Founded 1908
Sector Life Science
Employees4,285
Revenue 1.4B EUR (2022)
DESCRIPTION

LEO Pharma engages in medical dermatology with a robust R&D pipeline, a wide range of therapies, and a pioneering spirit. LEO Pharma supports people in managing their skin conditions. LEO Pharma was founded in 1908 and is based in Ballerup, Denmark.

DEAL STATS #
Overall 2 of 2
Sector: Life Science M&A 2 of 2
Type: Special Situations/Distressed M&A Deals 1 of 1
State: New Jersey M&A 1 of 1
Country: United States M&A 2 of 2
Year: 2024 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2020-07-21 LEO PDE4 Inhibitor

Ballerup, Denmark

LEO PDE4 Inhibitor compound series has the potential for the treatment of psoriasis and other immune-dermatological disorders.

Sell $200M
Mergr

Solution for

Product

Company

Legal